A detailed history of Virtus ETF Advisers LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,919 shares of ARCT stock, worth $48,251. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,919
Previous 2,865 1.88%
Holding current value
$48,251
Previous $69,000 2.9%
% of portfolio
0.03%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.08 - $25.38 $976 - $1,370
54 Added 1.88%
2,919 $67,000
Q2 2024

Aug 14, 2024

SELL
$24.35 - $44.39 $5,405 - $9,854
-222 Reduced 7.19%
2,865 $69,000
Q1 2024

May 15, 2024

SELL
$31.23 - $42.99 $6,714 - $9,242
-215 Reduced 6.51%
3,087 $104,000
Q4 2023

Feb 15, 2024

SELL
$17.71 - $32.97 $4,958 - $9,231
-280 Reduced 7.82%
3,302 $104,000
Q3 2023

Nov 07, 2023

SELL
$25.44 - $37.35 $9,005 - $13,221
-354 Reduced 8.99%
3,582 $91,000
Q2 2023

Aug 14, 2023

SELL
$23.94 - $32.36 $34,258 - $46,307
-1,431 Reduced 26.66%
3,936 $112,000
Q1 2023

May 15, 2023

SELL
$14.72 - $23.97 $30,382 - $49,474
-2,064 Reduced 27.78%
5,367 $128,000
Q4 2022

Feb 14, 2023

SELL
$14.14 - $23.06 $9,346 - $15,242
-661 Reduced 8.17%
7,431 $126,000
Q3 2022

Nov 14, 2022

BUY
$13.05 - $22.13 $691 - $1,172
53 Added 0.66%
8,092 $120,000
Q2 2022

Aug 12, 2022

BUY
$12.26 - $31.17 $42,995 - $109,313
3,507 Added 77.38%
8,039 $127,000
Q1 2022

May 16, 2022

SELL
$17.64 - $39.57 $4,780 - $10,723
-271 Reduced 5.64%
4,532 $122,000
Q4 2021

Feb 14, 2022

SELL
$34.2 - $47.56 $37,962 - $52,791
-1,110 Reduced 18.77%
4,803 $178,000
Q3 2021

Nov 15, 2021

SELL
$27.88 - $58.25 $8,810 - $18,407
-316 Reduced 5.07%
5,913 $283,000
Q2 2021

Aug 10, 2021

BUY
$25.79 - $42.11 $88,820 - $145,026
3,444 Added 123.66%
6,229 $211,000
Q1 2021

May 17, 2021

BUY
$38.75 - $86.92 $1,627 - $3,650
42 Added 1.53%
2,785 $115,000
Q4 2020

Feb 12, 2021

BUY
$34.61 - $123.66 $94,935 - $339,199
2,743 New
2,743 $119,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.